InnovAge (INNV) Competitors

InnovAge (NASDAQ:INNV) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

Do institutionals & insiders hold more shares of INNV or CELC?

12.3% of InnovAge shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 1.4% of InnovAge shares are held by insiders. Comparatively, 15.8% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Is INNV or CELC more profitable?

Celcuity has a net margin of 0.00% compared to InnovAge's net margin of -3.75%. InnovAge's return on equity of -11.91% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-3.75%	-11.91%	-5.85%
Celcuity	N/A	-126.74%	-60.59%

Do analysts rate INNV or CELC?

InnovAge presently has a consensus price target of $5.00, suggesting a potential upside of 45.77%. Celcuity has a consensus price target of $47.40, suggesting a potential downside of 8.48%. Given InnovAge's higher possible upside, equities research analysts plainly believe InnovAge is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Celcuity	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer INNV or CELC?

In the previous week, Celcuity had 8 more articles in the media than InnovAge. MarketBeat recorded 14 mentions for Celcuity and 6 mentions for InnovAge. InnovAge's average media sentiment score of 1.65 beat Celcuity's score of -0.10 indicating that InnovAge is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Celcuity	1 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more risk & volatility, INNV or CELC?

InnovAge has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500.

Which has higher earnings & valuation, INNV or CELC?

InnovAge has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$763.85M	0.61	-$21.34M	-$0.23	-14.91
Celcuity	N/A	N/A	-$111.78M	-$3.45	-15.01

Summary

InnovAge beats Celcuity on 8 of the 15 factors compared between the two stocks.